Drug Shortage Report for LINEZOLID INJECTION
Report ID | 90630 |
Drug Identification Number | 02430827 |
Brand name | LINEZOLID INJECTION |
Common or Proper name | Linezolid |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | LINEZOLID |
Strength(s) | 2MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 300mL |
ATC code | J01XX |
ATC description | OTHER ANTIBACTERIALS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-08-02 |
Actual start date | |
Estimated end date | 2019-08-30 |
Actual end date | 2019-09-13 |
Shortage status | Resolved |
Updated date | 2019-09-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-08-02 | English | Compare |
v2 | 2019-08-02 | French | Compare |
v3 | 2019-08-03 | English | Compare |
v4 | 2019-09-13 | English | Compare |
v5 | 2019-09-13 | French | Compare |
v6 | 2019-09-14 | English | Compare |
Showing 1 to 6 of 6